<SEC-DOCUMENT>0001935979-24-000048-index.html : 20240509
<SEC-HEADER>0001935979-24-000048.hdr.sgml : 20240509
<ACCEPTANCE-DATETIME>20240509161650
ACCESSION NUMBER:		0001935979-24-000048
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
REFERENCES 429:			333-267818
REFERENCES 429:			333-271886
FILED AS OF DATE:		20240509
DATE AS OF CHANGE:		20240509
EFFECTIVENESS DATE:		20240509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Biohaven Ltd.
		CENTRAL INDEX KEY:			0001935979
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-279258
		FILM NUMBER:		24930923

	BUSINESS ADDRESS:	
		STREET 1:		215 CHURCH STREET
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510
		BUSINESS PHONE:		203-404-0410

	MAIL ADDRESS:	
		STREET 1:		215 CHURCH STREET
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06510

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biohaven Research Ltd.
		DATE OF NAME CHANGE:	20220629
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>a2024bhvnltds-8q12024.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: a2024bhvnltds-8q12024.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exhibit107-sx8q12024.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 2 - file: exhibit107-sx8q12024.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51-sx8q12024.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: exhibit51-sx8q12024.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exhibit231-sx8q12024.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 4 - file: exhibit231-sx8q12024.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_0.jpg
<TEXT>
Document 5 - file: image_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_1.jpg
<TEXT>
Document 6 - file: image_1.jpg

</DOCUMENT>
</SEC-DOCUMENT>